Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for OPTIMIERTE BISPEZIFISCHE ANTI-CD3-ANTIKÖRPER UND VERWENDUNGEN DAVON
Details for 2016781236
Up to date per 13.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2016781236
Title / Product Name
OPTIMIERTE BISPEZIFISCHE ANTI-CD3-ANTIKÖRPER UND VERWENDUNGEN DAVON
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2016781236
EP Publication Number
3353212
E-Number
1443910
Language
EN
PCT Number
US16053525
Publication Date
01.08.2018 A
03.11.2021 B1
Registration Date
03.11.2021
AT Publication Date
15.11.2021
Application Date
23.09.2016
Registration Number
-
Priorities
23.09.2015
US
201562222605 P
IPC
C07K 16/28 20060101AFI20200819BHEP
Maximum Duration of Protection
23.09.2036
Owner
Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591-6707
US
Representative
Representative
Patentanwaltskanzlei Matschnig & Forsthuber OG
Biberstraße 22
1010 Wien
AT
Inventor
SMITH, Eric
Tarrytown, New York 10591-6707
US
HABER, Lauric
Tarrytown, New York 10591-6707
US
BABB, Robert
Tarrytown, New York 10591-6707
US
CHEN, Gang
Tarrytown, New York 10591-6707
US
MACDONALD, Douglas
Tarrytown, New York 10591-6707
US
Information about Fees
Click here to load the fees